To the Editor: Isoniazid is used extensively for the treatment of active and latent tuberculosis (TB). It is generally well tolerated by children, and hypersensitivity reactions resulting in skin rash and requiring cessation of treatment are rarely reported in this age group.1,2
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Tony D Merritt1
- Peter D Massey2
- 1 Hunter New England Population Health, Newcastle, NSW.
- 2 Hunter New England Population Health, Tamworth, NSW.
Correspondence: tony.merritt@hnehealth.nsw.gov.au
Online responses are no longer available. Please refer to our instructions for authors page for more information.